Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

Blood

Volumn 121, Issue 10, 2013, Pages 1896-1905

  Petersdorf, Effie W ^a   Malkki, Mari ^a   Horowitz, Mary M ^b   Spellman, Stephen R ^c   Haagenson, Michael D ^c   Wang, Tao ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Center for International Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MISMATCH REPAIR; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; UNRELATED DONORS;

EID: 84876589420     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-11-465161     Document Type: Article

References (34)

1. Foeken LM, Green A, Hurley CK, et al Donor Registries Working Group of the World Marrow Donor Association (WMDA). Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant. 2010;45(5):811-818.
2. Petz LD, Spellman SS, Gragert L. The underutilization of cord blood transplantation: extent of the problem, causes, and methods improvement. In: Broxmeyer HE, ed. Cord Blood: Biology, Transplantation, Banking, and Regulation. Bethesda, MD: AABB Press; 2011: 557-584.
3. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility- complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345(25): 1794-1800.
4. Lee SJ, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13): 4576-4583. (Pubitemid 351377826)
5. Trowsdale J. The MHC, disease and selection. Immunol Lett. 2011;137(1-2):1-8.
6. International HapMap 3 Consortium, Altshuler DM, Gibbs RA, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467(7311):52-58.
7. Miretti MM, Walsh EC, Ke X, et al. A highresolution linkage- disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005;76(4): 634-646. (Pubitemid 40432170)
8. Baker KS, Davies SM, Majhail NS, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15(12):1543-1554.
9. HLA Informatics Group, The Anthony Nolan Trust. HLA nomenclature. Available at: http://hla.alleles. org/wmda/index.html. Accessed May 1, 2012.
10. Mickelson E, Hurley C, Ng J, et al. Cell and Gene Bank and reference cell panels. In: Hansen J, ed. Immunobiology of the Human MHC. Seattle, WA: International Histocompatibility Working Group Press; 2006:523-553.
11. Petersdorf EW, Malkki M, Gooley TA, et al. MHC resident variation affects risks after unrelated donor hematopoietic cell transplantation. Sci Transl Med. 2012;4(144):144ra101.
12. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet. 1995;9(4):341-342.
13. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
14. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005;105(12):4878-4884. (Pubitemid 40807317)
15. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
16. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
17. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
18. Warnes G, Gorjanc G, Leisch F, Man M. Package R "Genetics" 1.3.4. Available at: http://cran.r-project.org/web/packages/genetics/. Accessed August 20, 2008.
19. National Center for Biotechnology Information. dbSNP database. Available at: http://www.ncbi. nlm.nih.gov/projects/SNP/. Accessed June 10, 2012.
20. Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004; 5(12):889-899. (Pubitemid 39564252)
21. National Library of Medicine. National Center for Biotechnology information public website. Available at: http://www.ncbi.nlm.nih.gov/projects/ mapview/maps.cgi?taxid=9606&chr=6. Accessed October 25, 2012.
22. Martin PJ. Overview of hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, et al, eds. Thomas' Hematopoietic Cell Transplantation. 4th Ed. West Sussex, United Kingdom: Wiley-Blackwell; 2008:131-144.
23. Horowitz MM, Gale RP, Sondel PM, et al. Graftversus-leukemia reactions after bone marrow transplantation. Blood. 1990;75(3):555-562. (Pubitemid 20069191)
24. Ferrara JL, Levine JE, Reddy P, et al. Graftversus-host disease. Lancet. 2009;373(9674): 1550-1561.
25. Kolb H-J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 2008;112(12):4371-4383.
26. Ringd'en O, Labopin M, Gorin NC, et al Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia? Br J Haematol. 2000;111(4): 1130-1137. (Pubitemid 32104929)
27. Morishima S, Ogawa S, Matsubara A, et al Japan Marrow Donor Program. Impact of highly conserved HLA haplotype on acute graft-versushost disease. Blood. 2010;115(23):4664-4670.
28. Harkensee C, Oka A, Onizuka M, et al Japan Marrow Donor Program. Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study. Blood. 2012;119(26):6365-6372.
29. Spellman SR, Eapen M, Logan BR, et al National Marrow Donor Program; Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120(2):259-265.
30. Hood AF, Vogelsang GB, Black LP, et al. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol. 1987;123(6): 745-750. (Pubitemid 17076166)
31. Busch R, Rinderknecht CH, Roh S, et al. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol Rev. 2005; 207(1):242-260. (Pubitemid 41415022)
32. Fourie AM, Peterson PA, Yang Y. Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2. Cell Stress Chaperones. 2001;6(3):282-295. (Pubitemid 32912013)
33. Zhang Y, Sandy AR, Wang J, et al. Notch signaling is a critical regulator of allogeneic CD41 T-cell responses mediating graft-versus-host disease. Blood. 2011;117(1):299-308.
34. SNP and CNV annotation database (SCAN). Available at: http://www.scandb.org/newinterface/about.html. Accessed June 12, 2012.